Skip to main content
. 2020 Sep 16;52(3):317–334. doi: 10.3947/ic.2020.52.3.317

Figure 2. Meta-analysis of hydroxychloroquine and hydroxychloroquine combined with azithromycin in relation to the risk of mortality in COVID-19 patients.

Figure 2